HIV Epidemic

Challenges in Infectious Diseases

Volumn , Issue , 2013, Pages 3-46

  Vermund, Sten H ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85006336576     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4496-1_1     Document Type: Chapter

References (432)

1. McEvedy C (1988) The bubonic plague. Sci Am 258:118-123
2. Haensch S, Bianucci R, Signoli M et al (2010) Distinct clones of Yersinia pestis caused the black death. PLoS Pathog 6:e1001134
3. Vermund SH, Leigh-Brown AJ (2012) The HIV epidemic: high-income countries. In: Bushman FD, Nabel GJ, Swanstrom R (eds) HIV: from biology to prevention and treatment, 1st edn. Cold Spring Harbor Laboratory Press, New York, pp 385-408
4. Shao Y, Williamson C (2012) The HIV-1 epidemic: low-to middle-income countries. In: Bushman FD, Nabel GJ, Swanstrom R (eds) HIV: from biology to prevention and treatment, 1st edn. Cold Spring Harbor Laboratory Press, New York, pp 367-383
5. Stephenson I (2005) Are we ready for pandemic in fluenza H5N1? Expert Rev Vac 4:151-155
6. Monto AS (2009) The risk of seasonal and pandemic in fluenza: prospects for control. Clin Infect Dis 48(Suppl 1):S20-S25
7. Fedson DS (2009) Meeting the challenge of in fluenza pandemic preparedness in developing countries. Emerg Infect Dis 15:365-371
8. Fedson DS (2006) Vaccine development for an imminent pandemic: why we should worry, what we must do. Hum Vac 2:38-42
9. Chavers LS, Vermund SH (2007) An introduction to emerging and reemerging infectious diseases. In: Lashley FR, Durham JD (eds) Emerging infectious diseases: trends and issues, 2nd edn. Springer Publishing Company, New York, pp 3-24
10. Karim QA, Kharsany AB, Frohlich JA et al (2011) Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol 40:922-930
11. Baggaley RF, Fraser C (2010) Modelling sexual transmission of HIV: testing the assumptions, validating the predictions. Curr Opin HIV AIDS 5:269-276
12. Blower S, Schwartz EJ, Mills J (2003) Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev 5:113-125
13. Center for Disease Control and Prevention, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR: Morb Mort Wkly Rep Recomm Rep/RR-17 41:1-5
14. (UNAIDS) JUNPoHA (2011) UNAIDS: World AIDS day report, 2011. Report No.: 978-92-9173-904-2. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland
15. (UNAIDS) JUNPoHA (2010) Global report: UNAIDS report on global AIDS epidemic 2010. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland
16. Ki-moon B, Zuma J, Piot P et al (2011) AIDS at 30: Nations at the crossroads: Joint United Nations Programme on HIV/AIDS (UNAIDS)
17. Kipp W, Chapman E, Jhangri GS et al (2009) Fourteen years of surveillance of HIV-1 prevalence among pregnant women attending antenatal care clinics in western Uganda. Int J STD AIDS 20:499-502
18. Stoneburner RL, Low-Beer D (2004) Population-level HIV declines and behavioral risk avoidance in Uganda. Science 304:714-718
19. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC (1994) Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 344:243-245
20. Nelson KE, Celentano DD, Eiumtrakol S et al (1996) Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 335:297-303
21. Celentano DD, Nelson KE, Lyles CM et al (1998) Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS 12:F29-F36
22. Hargrove JW, Humphrey JH, Mahomva A et al (2011) Declining HIV prevalence and incidence in perinatal women in Harare, Zimbabwe. Epidemics 3:88-94
23. Marsh KA, Nyamukapa CA, Donnelly CA et al (2011) Monitoring trends in HIV prevalence among young people, aged 15 to 24 years, in Manicaland, Zimbabwe. J Intern AIDS Soc 14:27
24. Halperin DT, Mugurungi O, Hallett TB et al (2011) A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med 8:e1000414
25. Gregson S, Nyamukapa C, Schumacher C et al (2011) Did national HIV prevention programs contribute to HIV decline in Eastern Zimbabwe? Evidence from a prospective community survey. Sex Transm Dis 38:475-482
26. International Group on Analysis of Trends in HIVP, Behaviours in Young People in Countries most Affected by HIV (2010) Trends in HIV prevalence and sexual behaviour among young people aged 15-24 years in countries most affected by HIV. Sex Transm Infect 86 (Suppl 2):ii72-ii83
27. Gregson S, Gonese E, Hallett TB et al (2010) HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol 39:1311-1323
28. Gouws E, Stanecki KA, Lyerla R, Ghys PD (2008) The epidemiology of HIV infection among young people aged 15-24 years in southern Africa. AIDS 22(Suppl 4):S5-S16
29. Lopman B, Gregson S (2008) When did HIV incidence peak in Harare, Zimbabwe? Backcalculation from mortality statistics. PLoS One 3:e1711
30. Dube S, Boily MC, Mugurungi O, Mahomva A, Chikhata F, Gregson S (2008) Estimating vertically acquired HIV infections and the impact of the prevention of mother-to-child transmission program in Zimbabwe: insights from decision analysis models. J Acquir Immune Defic Syndr 48:72-81
31. Lopman B, Nyamukapa C, Mushati P et al (2008) HIV incidence in 3 years of follow-up of a Zimbabwe cohort-1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol 37:88-105
32. Mahomva A, Greby S, Dube S et al (2006) HIV prevalence and trends from data in Zimbabwe, 1997-2004. Sex Transm Infect 82(Suppl 1):i42-i47
33. Gregson S, Garnett GP, Nyamukapa CA et al (2006) HIV decline associated with behavior change in eastern Zimbabwe. Science 311:664-666
34. Wawer MJ, Serwadda D, Gray RH et al (1997) Trends in HIV-1 prevalence may not re flect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS 11:1023-1030
35. Das M, Chu PL, Santos GM et al (2010) Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 5:e11068
36. Kilmarx PH (2009) Global epidemiology of HIV. Curr Opin HIV AIDS 4:240-246
37. Baral S, Sifakis F, Cleghorn F, Beyrer C (2007) Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review. PLoS Med 4:e339
38. Oster AM, Wiegand RE, Sionean C et al (2011) Understanding disparities in HIV infection between black and white MSM in the United States. AIDS 25:1103-1112
39. Lieb S, Prejean J, Thompson DR et al (2011) HIV prevalence rates among men who have sex with men in the southern United States: population-based estimates by race/ethnicity. AIDS Behav 15:596-606
40. El-Sadr WM, Mayer KH, Hodder SL (2010) AIDS in America-forgotten but not gone. N Engl J Med 362:967-970
41. Vermund SH, Hodder SL, Justman JE et al (2010) Addressing research priorities for prevention of HIV infection in the United States. Clin Infect Dis 50(Suppl 3):S149-S155
42. Hamers FF, Downs AM (2003) HIV in central and eastern Europe. Lancet 361:1035-1044
43. Aceijas C, Stimson GV, Hickman M et al (2004) Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18:2295-2303
44. Beyrer C, Wirtz AL, Walker D, Johns B, Sifakis F, Baral SD (2011) The global HIV epidemics among men who have sex with men. World Bank, Washington, DC
45. Larson HJ, Bertozzi S, Piot P (2011) Redesigning the AIDS response for long-term impact. WHO Bull 89:846-852
46. Schwartlander B, Stover J, Hallett T et al (2011) Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 377:2031-2041
47. Hogan DR, Salomon JA (2005) Prevention and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome in resource-limited settings. WHO Bull 83:135-143
48. Vergara AE, Assan A, Vermund SH (2009) Principles and experiences in national antiretroviral therapy roll-out. In: Marlink RG, Teitelman SJ (eds) From the ground up: building comprehensive HIV/AIDS care programs in resource-limited settings. Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, pp 1-14
49. Fowler MG, Gable AR, Lampe MA, Etima M, Owor M (2010) Perinatal HIV and its prevention: progress toward an HIV-free generation. Clin Perinatol 37:699-719
50. Mofenson LM (2010) Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection. Clin Infect Dis 50(Suppl 3):S130-S148
51. Goldenberg RL, Stringer JS, Sinkala M, Vermund SH (2002) Perinatal HIV transmission: developing country considerations. J Matern Fetal Neonatal Med 12:149-158
52. Newell ML, Brahmbhatt H, Ghys PD (2004) Child mortality and HIV infection in Africa: a review. AIDS 18(Suppl 2):S27-S34
53. Ding H, Wilson CM, Modjarrad K, McGwin G Jr, Tang J, Vermund SH (2009) Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project. Arch Pediatr Adolesc Med 163:1100-1105
54. Stringer EM, Ekouevi DK, Coetzee D et al (2010) Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA 304:293-302
55. Megazzini KM, Sinkala M, Vermund SH et al (2010) A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia. AIDS 24:447-455
56. Stringer EM, Chi BH, Chintu N et al (2008) Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. WHO Bull 86:57-62
57. Reithinger R, Megazzini K, Durako SJ, Harris DR, Vermund SH (2007) Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in Africa. BMJ 334:1143-1146
58. Potter D, Goldenberg RL, Chao A et al (2008) Do targeted HIV programs improve overall care for pregnant women? Antenatal syphilis management in Zambia before and after implementation of prevention of mother-to-child HIV transmission programs. J Acquir Immune Defic Syndr 47:79-85
59. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA et al (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 298:1888-1899
60. Stringer JS, Sinkala M, Maclean CC et al (2005) Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS 19:1309-1315
61. Stringer EM, Sinkala M, Stringer JS et al (2003) Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS 17:1377-1382
62. Galarraga O, Wirtz VJ, Figueroa-Lara A et al (2011) Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics 29:579-599
63. Ciaranello AL, Park JE, Ramirez-Avila L, Freedberg KA, Walensky RP, Leroy V (2011) Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med 9:59
64. Ciampa PJ, Burlison JR, Blevins M et al (2011) Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr 58:115-119
65. Violari A, Cotton MF, Gibb DM et al (2008) Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 359:2233-2244
66. UNAIDS: World AIDS Day Report 2011: core epidemiology slides. Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011. http://www.slideshare.net/UNAIDS/unaidsworld-aids-day-report-2011-core-slides-10250153. Accessed 22 Jan 2012
67. Kourtis AP, Kraft JM, Gavin L, Kissin D, McMichen-Wright P, Jamieson DJ (2006) Prevention of sexually transmitted human immunodeficiency virus (HIV) infection in adolescents. Curr HIV Res 4:209-219
68. Underhill K, Operario D, Montgomery P (2007) Systematic review of abstinence-plus HIV prevention programs in high-income countries. PLoS Med 4:e275
69. Gavin L, MacKay AP, Brown K et al (2009) Sexual and reproductive health of persons aged 10-24 years - United States, 2002-2007. MMWR Surveill Summ 58:1-58
70. DiClemente RJ, Crittenden CP, Rose E et al (2008) Psychosocial predictors of HIV-associated sexual behaviors and the efficacy of prevention interventions in adolescents at-risk for HIV infection: what works and what doesn't work? Psychosom Med 70:598-605
71. Spiegel HM, Futterman DC (2009) Adolescents and HIV: prevention and clinical care. Curr HIV/AIDS Rep 6:100-107
72. Boutayeb A (2009) The impact of HIV/AIDS on human development in African countries. BMC Public Health 9(Suppl 1):S3
73. Ferreira PC, Pessoa S, Santos MR (2011) The impact of AIDS on income and human capital. Econ Inq 49:1104-1116
74. Galarraga O, Colchero MA, Wamai RG, Bertozzi SM (2009) HIV prevention cost-effectiveness: a systematic review. BMC Public Health 9(Suppl 1):S5
75. Thurlow J, Gow J, George G (2009) HIV/AIDS, growth and poverty in KwaZulu-Natal and South Africa: an integrated survey, demographic and economy-wide analysis. J Int AIDS Soc 12:18
76. Hunter SS, Bulirwa E, Kisseka E (1993) AIDS and agricultural production. Report of a land utilization survey, Masaka and Rakai districts of Uganda. Land Use Policy 10:241-258
77. Nabyonga-Orem J, Bazeyo W, Okema A, Karamagi H, Walker O (2008) Effect of HIV/AIDS on household welfare in Uganda rural communities: a review. East Afr Med J 85:187-196
78. Hosegood V, Preston-Whyte E, Busza J, Moitse S, Timaeus IM (2007) Revealing the full extent of households' experiences of HIV and AIDS in rural South Africa. Soc Sci Med 65:1249-1259
79. Andrews G, Skinner D, Zuma K (2006) Epidemiology of health and vulnerability among children orphaned and made vulnerable by HIV/AIDS in sub-Saharan Africa. AIDS Care 18:269-276
80. Lawn SD, Wood R (2011) Tuberculosis in antiretroviral treatment services in resourcelimited settings: addressing the challenges of screening and diagnosis. J Infect Dis 204 (Suppl 4):S1159-S1167
81. Venkatesh KK, Swaminathan S, Andrews JR, Mayer KH (2011) Tuberculosis and HIV coinfection: screening and treatment strategies. Drugs 71:1133-1152
82. Wood R, Lawn SD, Johnstone-Robertson S, Bekker LG (2011) Tuberculosis control has failed in South Africa-time to reappraise strategy. South Afr Med J 101:111-114
83. Martinson NA, Hoffmann CJ, Chaisson RE (2011) Epidemiology of tuberculosis and HIV: recent advances in understanding and responses. Proc Am Thorac Soc 8:288-293
84. Kwan CK, Ernst JD (2011) HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 24:351-376
85. Lawn SD, Zumla AI (2011) Tuberculosis. Lancet 378:57-72
86. Nachega JB, Rosenkranz B, Simon G, Chaisson RE, Diacon A, Taljaard J (2011) Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectives. Infect Disord Drug Targets 11:134-143
87. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH (2012) Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res 5:11-17
88. Casper C (2011) The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med 62:157-170
89. Barnabas RV, Webb EL, Weiss HA, Wasserheit JN (2011) The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS 25:1559-1573
90. Modjarrad K, Vermund SH (2010) Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 10:455-463
91. Modjarrad K, Vermund SH (2011) An addition to the effect of treating co-infections on HIV-1 viral load. Lancet Infect Dis 11:81
92. Koethe JR, Heimburger DC (2010) Nutritional aspects of HIV-associated wasting in sub-Saharan Africa. Am J Clin Nutr 91:1138S-1142S
93. Koethe JR, Chi BH, Megazzini KM, Heimburger DC, Stringer JS (2009) Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resourceadequate and resource-constrained settings. Clin Infect Dis 49:787-798
94. van Oosterhout JJ, Ndekha M, Moore E, Kumwenda JJ, Zijlstra EE, Manary M (2010) The benefit of supplementary feeding for wasted Malawian adults initiating ART. AIDS Care 22:737-742
95. Ahoua L, Umutoni C, Huerga H et al (2011) Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: a longitudinal study. J Int AIDS Soc 14:2
96. Manary M, Ndekhat M, van Oosterhout JJ (2010) Supplementary feeding in the care of the wasted HIV infected patient. Malawi Med J 22:46-48
97. Peterse I, Swartz L (2002) Primary health care in the era of HIV/AIDS. some implications for health systems reform. Soc Sci Med 55:1005-1013
98. Benatar SR (2004) Health care reform and the crisis of HIV and AIDS in South Africa. N Engl J Med 351:81-92
99. Dohrn J, Nzama B, Murrman M (2009) The impact of HIV scale-up on the role of nurses in South Africa: time for a new approach. J Acquir Immune Defic Syndr 52(Suppl 1):S27-S29
100. Chopra M, Lawn JE, Sanders D et al (2009) Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet 374:1023-1031
101. Auvert B, Ballard R, Campbell C et al (2001) HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS 15:885-898
102. Vermund SH, Allen KL, Karim QA (2009) HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS 4:266-273
103. Eyawo O, de Walque D, Ford N, Gakii G, Lester RT, Mills EJ (2010) HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 10:770-777
104. Vlahov D, Robertson AM, Strathdee SA (2010) Prevention of HIV infection among injection drug users in resource-limited settings. Clin Infect Dis 50(Suppl 3):S114-S121
105. McCurdy SA, Ross MW, Williams ML, Kilonzo GP, Leshabari MT (2010) Flashblood: blood sharing among female injecting drug users in Tanzania. Addiction 105:1062-1070
106. Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW (2009) Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Lancet 374:416-422
107. Baral S, Adams D, Lebona J et al (2011) A cross-sectional assessment of population demographics, HIV risks and human rights contexts among men who have sex with men in Lesotho. J Int AIDS Soc 14:36
108. Rispel LC, Metcalf CA, Cloete A, Reddy V, Lombard C (2011) HIV prevalence and risk practices among men who have sex with men in two South African cities. J Acquir Immune Defic Syndr 57:69-76
109. Merrigan M, Azeez A, Afolabi B et al (2011) HIV prevalence and risk behaviours among men having sex with men in Nigeria. Sex Transm Infect 87:65-70
110. Johnston LG, Holman A, Dahoma M et al (2010) HIV risk and the overlap of injecting drug use and high-risk sexual behaviours among men who have sex with men in Zanzibar (Unguja), Tanzania. Int J Drug Policy 21:485-492
111. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M (1999) Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. WHO Bull 77:789-800
112. Centers for Disease Control & Prevention (2011) Progress toward strengthening national blood transfusion services-14 countries, 2008-2010. MMWR Morb Mortal Wkly Rep 60:1577-1582
113. Hussain A, Moodley D, Naidoo S, Esterhuizen TM (2011) Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment. PLoS One 6:e27907
114. Stinson K, Boulle A, Coetzee D, Abrams EJ, Myer L (2010) Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health 15:825-832
115. Ekouevi DK, Coffie PA, Becquet R et al (2008) Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Cote d'Ivoire. AIDS 22:1815-1820
116. Kumwenda J, Matchere F, Mataya R et al (2011) Coverage of highly active antiretroviral therapy among postpartum women in Malawi. Int J STD AIDS 22:368-372
117. Chen JY, Ogwu AC, Svab P et al (2010) Antiretroviral treatment initiation among HIVinfected pregnant women with low CD4(+) cell counts in Gaborone, Botswana. J Acquir Immune Defic Syndr 54:102-106
118. Bancheno WM, Mwanyumba F, Mareverwa J (2010) Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa. AIDS Care 22:1130-1135
119. Horwood C, Haskins L, Vermaak K, Phakathi S, Subbaye R, Doherty T (2010) Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women's health services. Trop Med Int Health 15:992-999
120. Davaalkham J, Unenchimeg P, Baigalmaa C et al (2009) High-risk status of HIV-1 infection in the very low epidemic country, Mongolia, 2007. Int J STD AIDS 20:391-394
121. Nemoto T (2004) HIV/AIDS surveillance and prevention studies in Japan: summary and recommendations. AIDS Educ Prev 16:27-42
122. Farr AC, Wilson DP (2010) An HIV epidemic is ready to emerge in the Philippines. J Int AIDS Soc 13:16
123. van Griensven F, de Lind van Wijngaarden JW (2010) A review of the epidemiology of HIV infection and prevention responses among MSM in Asia. AIDS 24(Suppl 3):S30-S40
124. Sharma M, Oppenheimer E, Saidel T, Loo V, Garg R (2009) A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region. AIDS 23:1405-1413
125. Ruxrungtham K, Brown T, Phanuphak P (2004) HIV/AIDS in Asia. Lancet 364:69-82
126. Couture MC, Sansothy N, Sapphon V et al (2011) Young women engaged in sex work in Phnom Penh, Cambodia, have high incidence of HIV and sexually transmitted infections, and amphetamine-type stimulant use: new challenges to HIV prevention and risk. Sex Transm Dis 38:33-39
127. Park LS, Siraprapasiri T, Peerapatanapokin W, Manne J, Niccolai L, Kunanusont C (2010) HIV transmission rates in Thailand: evidence of HIV prevention and transmission decline. J Acquir Immune Defic Syndr 54:430-436
128. Ainsworth M, Beyrer C, Soucat A (2003) AIDS and public policy: the lessons and challenges of "success" in Thailand. Health Policy 64:13-37
129. Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R (2007) Evolution of China's response to HIV/AIDS. Lancet 369:679-690
130. Xiao Y, Kristensen S, Sun J, Lu L, Vermund SH (2007) Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med 64:665-675
131. Tucker JD, Cohen MS (2011) China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses. Curr Opin Infect Dis 24:50-55
132. Qian HZ, Vermund SH, Wang N (2005) Risk of HIV/AIDS in China: subpopulations of special importance. Sex Transm Infect 81:442-447
133. Qian HZ, Vermund SH, Kaslow RA et al (2006) Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS 20:1429-1435
134. Chandrasekaran P, Dallabetta G, Loo V, Rao S, Gayle H, Alexander A (2006) Containing HIV/AIDS in India: the unfinished agenda. Lancet Infect Dis 6:508-521
135. Dandona L, Lakshmi V, Kumar GA, Dandona R (2006) Is the HIV burden in India being overestimated? BMC Public Health 6:308
136. Siddiqui AU, Qian HZ, Altaf A, Cassell H, Shah SA, Vermund SH (2011) Condom use during commercial sex among clients of Hijra sex workers in Karachi, Pakistan (cross-sectional study). BMJ Open 1:e000154
137. Sahastrabuddhe S, Gupta A, Stuart E et al (2012) Sexually transmitted infections and risk behaviors among transgender persons (Hijras) of Pune, India. J Acquir Immune Defic Syndr 59:72-78
138. Shaw SY, Emmanuel F, Adrien A et al (2011) The descriptive epidemiology of male sex workers in Pakistan: a biological and behavioural examination. Sex Transm Infect 87:73-80
139. Phillips AE, Lowndes CM, Boily MC et al (2010) Men who have sex with men and women in Bangalore, South India, and potential impact on the HIV epidemic. Sex Transm Infect 86:187-192
140. Solomon SS, Srikrishnan AK, Sifakis F et al (2010) The emerging HIV epidemic among men who have sex with men in Tamil Nadu, India: geographic diffusion and bisexual concurrency. AIDS Behav 14:1001-1010
141. Verma R, Shekhar A, Khobragade S et al (2010) Scale-up and coverage of Avahan: a largescale HIV-prevention programme among female sex workers and men who have sex with men in four Indian states. Sex Transm Infect 86(Suppl 1):i76-i82
142. Altaf A, Saleem N, Abbas S, Muzaffar R (2009) High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan. J Pak Med Assoc 59:136-140
143. Vermund SH, White H, Shah SA et al (2006) HIV/AIDS in Pakistan: has the explosion begun? J Pak Med Assoc 56:S1-S2
144. Kazi AM, Shah SA, Jenkins CA, Shepherd BE, Vermund SH (2010) Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan. Int J Infect Dis 14(Suppl 3):e60-e66
145. Mathers BM, Degenhardt L, Ali H et al (2010) HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 375:1014-1028
146. Kelly JA, Amirkhanian YA (2003) The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe. Int J STD AIDS 14:361-371
147. Bridge J, Lazarus JV, Atun R (2010) HIV epidemics and prevention responses in Asia and Eastern Europe: lessons to be learned? AIDS 24(Suppl 3):S86-S94
148. Rechel B (2010) HIV/AIDS in the countries of the former Soviet Union: societal and attitudinal challenges. Cent Eur J Public Health 18:110-115
149. Elovich R, Drucker E (2008) On drug treatment and social control: Russian narcology's great leap backwards. Harm Reduct J 5:23
150. Tkatchenko-Schmidt E, Renton A, Gevorgyan R, Davydenko L, Atun R (2008) Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes. Health Policy 85:162-171
151. Kalichman SC, Kelly JA, Sikkema KJ, Koslov AP, Shaboltas A, Granskaya J (2000) The emerging AIDS crisis in Russia: review of enabling factors and prevention needs. Int J STD AIDS 11:71-75
152. Platt L, Rhodes T, Hickman M et al (2008) Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. J Acquir Immune Defic Syndr 47:623-631
153. Lurie P, Drucker E (1997) An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA. Lancet 349:604-608
154. Millett GA, Crowley JS, Koh H et al (2010) A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Syndr 55(Suppl 2):S144-S147
155. Mumtaz G, Hilmi N, McFarland W et al (2010) Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis. PLoS Med 8:e1000444
156. Shah SA, Khan OA, Kristensen S, Vermund SH (1999) HIV-infected workers deported from the Gulf States: impact on Southern Pakistan. Int J STD AIDS 10:812-814
157. Mumtaz G, Hilmi N, Akala FA et al (2011) HIV-1 molecular epidemiology evidence and transmission patterns in the Middle East and North Africa. Sex Transm Infect 87:101-106
158. Abu-Raddad LJ, Hilmi N, Mumtaz G et al (2010) Epidemiology of HIV infection in the Middle East and North Africa. AIDS 24(Suppl 2):S5-S23
159. Sawires S, Birnbaum N, Abu-Raddad L, Szekeres G, Gayle J (2009) Twenty-five years of HIV: lessons for low prevalence scenarios. J Acquir Immune Defic Syndr 51(Suppl 3): S75-S82
160. Todd CS, Nassiramanesh B, Stanekzai MR, Kamarulzaman A (2007) Emerging HIV epidemics in Muslim countries: assessment of different cultural responses to harm reduction and implications for HIV control. Curr HIV/AIDS Rep 4:151-157
161. Farnia M, Ebrahimi B, Shams A, Zamani S (2010) Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. Int J Drug Policy 21:422-424
162. Zamani S, Farnia M, Torknejad A et al (2010) Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran. J Urban Health 87:603-616
163. Zamani S, Farnia M, Tavakoli S et al (2010) A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran. Int J Drug Policy 21:167-172
164. Shoptaw S, Reback CJ (2007) Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction 102(Suppl 1):130-135
165. Colfax G, Shoptaw S (2005) The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2:194-199
166. Miller M (2003) The dynamics of substance use and sex networks in HIV transmission. J Urban Health 80:iii88-iii96
167. Goedert JJ (1984) Recreational drugs: relationship to AIDS. Ann N Y Acad Sci 437: 192-199
168. Drumright LN, Patterson TL, Strathdee SA (2006) Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review. Subst Use Misuse 41:1551-1601
169. Woolf SE, Maisto SA (2009) Alcohol use and risk of HIV infection among men who have sex with men. AIDS Behav 13:757-782
170. Wilson T, DeHovitz JA (1997) STDs, HIV, and crack cocaine: a review. AIDS Patient Care STDS 11:62-66
171. Corsi KF, Booth RE (2008) HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present. Curr Drug Abuse Rev 1:292-296
172. Zierler S, Krieger N (1997) Reframing women's risk: social inequalities and HIV infection. Annu Rev Public Health 18:401-436
173. Norris J, Masters NT, Zawacki T (2004) Cognitive mediation of women's sexual decision making: the in fluence of alcohol, contextual factors, and background variables. Annu Rev Sex Res 15:258-296
174. Senf JH, Price CQ (1994) Young adults, alcohol and condom use: what is the connection? J Adolesc Health 15:238-244
175. Fortenberry JD (1998) Alcohol, drugs, and STD/HIV risk among adolescents. AIDS Patient Care STDS 12:783-786
176. Millett GA, Peterson JL, Wolitski RJ, Stall R (2006) Greater risk for HIV infection of black men who have sex with men: a critical literature review. Am J Public Health 96:1007-1019
177. Lindegren ML, Byers RH Jr, Thomas P et al (1999) Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 282:531-538
178. Wortley PM, Lindegren ML, Fleming PL (2001) Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation. MMWR Morb Mort Wkly Rep Recomm Rep/CDC 50:17-28
179. Freeman P, Walker BC, Harris DR et al (2011) Methamphetamine use and risk for HIV among young men who have sex with men in 8 US cities. Arch Pediatr Adolesc Med 165:736-740
180. Whitmore SK, Taylor AW, Espinoza L, Shouse RL, Lampe MA, Nesheim S (2012) Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics 129:e74-e81
181. European Collaborative Study in E, Bailey H, Townsend C, Cortina-Borja M, Thorne C (2011) Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe. Antivir Ther 16:895-903
182. Cohen MS, Chen YQ, McCauley M et al (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365:493-505
183. Centers for Disease Control & Prevention (2011) Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep 60:1618-1623
184. Burns DN, Dieffenbach CW, Vermund SH (2010) Rethinking prevention of HIV type 1 infection. Clin Infect Dis 51:725-731
185. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ (2011) The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52:793-800
186. Montaner JS, Lima VD, Barrios R et al (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376:532-539
187. Caceres CF, Stall R (2003) Commentary: The human immunodeficiency virus/AIDS epidemic among men who have sex with men in Latin America and the Caribbean: it is time to bridge the gap. Int J Epidemiol 32:740-743
188. Fang CT, Hsu HM, Twu SJ et al (2004) Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis 190:879-885
189. McGowan CC, Cahn P, Gotuzzo E et al (2007) Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 36:969-976
190. Caceres CF (2002) HIV among gay and other men who have sex with men in Latin America and the Caribbean: a hidden epidemic? AIDS 16(Suppl 3):S23-S33
191. Coplan PM, Gortmaker S, Hernandez-Avila M, Spiegelman D, Uribe-Zuniga P, Mueller NE (1996) Human immunodeficiency virus infection in Mexico City. Rectal bleeding and anal warts as risk factors among men reporting sex with men. Am J Epidemiol 144:817-827
192. McCarthy MC, Wignall FS, Sanchez J et al (1996) The epidemiology of HIV-1 infection in Peru, 1986-1990. AIDS 10:1141-1145
193. Bastos FI, Caceres C, Galvao J, Veras MA, Castilho EA (2008) AIDS in Latin America: assessing the current status of the epidemic and the ongoing response. Int J Epidemiol 37:729-737
194. Lima ES, Friedman SR, Bastos FI et al (1994) Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro. Addiction 89:689-698
195. Hacker MA, Malta M, Enriquez M, Bastos FI (2005) Human immunodeficiency virus, AIDS, and drug consumption in South America and the Caribbean: epidemiological evidence and initiatives to curb the epidemic. Pan Am J Public Health 18:303-313
196. Rodriguez CM, Marques LF, Touze G (2002) HIV and injection drug use in Latin America. AIDS 16(Suppl 3):S34-S41
197. Caiaffa WT, Proietti FA, Carneiro-Proietti AB et al (2003) The dynamics of the human immunodeficiency virus epidemics in the south of Brazil: increasing role of injection drug users. Clin Infect Dis 37(Suppl 5):S376-S381
198. Khalsa JH, Francis H, Mazin R (2003) Bloodborne and sexually transmitted infections in drug abusers in the United States, Latin America, the Caribbean, and Spain. Clin Infect Dis 37(Suppl 5):S331-S337
199. Mesquita F, Doneda D, GandolfiD et al (2003) Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users. Clin Infect Dis 37(Suppl 5):S382-S385
200. Bastos FI, Caiaffa W, Rossi D, Vila M, Malta M (2007) The children of mama coca: coca, cocaine and the fate of harm reduction in South America. Int J Drug Policy 18:99-106
201. Damacena GN, Szwarcwald CL, de SouzaJunior PR, Dourado I (2011) Risk factors associated with HIV prevalence among female sex workers in 10 Brazilian cities. J Acquir Immune Defic Syndr 57(Suppl 3):S144-S152
202. Cortez FC, Boer DP, Baltieri DA (2011) Psychosocial pathways to inconsistent condom use among male sex workers: personality, drug misuse and criminality. Sex Health 8:390-398
203. Anastario M, Manzanero R, Blanco R et al (2011) HIV infection, sexual risk behaviour and condom use in the Belize defense force. Int J STD AIDS 22:73-9
204. Bassols AM, Boni R, Pechansky F (2010) Alcohol, drugs, and risky sexual behavior are related to HIV infection in female adolescents. Rev Bras Psiquiatr 32:361-368
205. von Diemen L, De Boni R, Kessler F, Benzano D, Pechansky F (2010) Risk behaviors for HCV- and HIV-seroprevalence among female crack users in Porto Alegre, Brazil. Arch Women's Ment Health 13:185-191
206. Ramirez J, Suarez E, de la Rosa G, Castro MA, Zimmerman MA (1994) AIDS knowledge and sexual behavior among Mexican gay and bisexual men. AIDS Educ Prev 6:163-174
207. Konda KA, Celentano DD, Kegeles S, Coates TJ, Caceres CF, Group NCHSPT (2011) Latent class analysis of sexual risk patterns among esquineros (street corner men) a group of heterosexually identified, socially marginalized men in urban coastal Peru. AIDS Behav 15:862-868
208. D'Ippolito M, Read JS, Korelitz J et al (2007) Missed opportunities for prevention of motherto-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NISDI perinatal study. Pediatr Infect Dis J 26:649-653
209. Read JS, Cahn P, Losso M et al (2007) Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites. Obstet Gynecol 109:1358-1367
210. Figueroa JP (2003) HIV/AIDS in the Caribbean. The need for a more effective public health response. West Indian Med J 52:156-158
211. Figueroa JP (2008) The HIV epidemic in the Caribbean: meeting the challenges of achieving universal access to prevention, treatment and care. West Indian Med J 57:195-203
212. Figueroa JP (2004) An overview of HIV/AIDS in Jamaica: strengthening the response. West Indian Med J 53:277-282
213. Calleja JM, Walker N, Cuchi P, Lazzari S, Ghys PD, Zacarias F (2002) Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. AIDS 16(Suppl 3):S3-S12
214. Inciardi JA, Syvertsen JL, Surratt HL (2005) HIV/AIDS in the Caribbean Basin. AIDS Care 17(Suppl 1):S9-S25
215. Castro A, Farmer P (2005) Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health 95:53-59
216. Pape J, Johnson WD Jr (1993) AIDS in Haiti: 1982-1992. Clin Infect Dis 17(Suppl 2):S341-S345
217. Dorjgochoo T, Noel F, Deschamps MM et al (2009) Risk factors for HIV infection among Haitian adolescents and young adults seeking counseling and testing in Port-au-Prince. J Acquir Immune Defic Syndr 52:498-508
218. Seguy N, Denniston M, Hladik W et al (2008) HIV and syphilis infection among gold and diamond miners-Guyana, 2004. West Indian Med J 57:444-449
219. Schumacher S, Norin J, Bolu O, DuBois A, Wolford J, Shaffer N (2009) HIV testing and counselling for prevention of mother-to-child transmission at labour and delivery in Guyana. West Indian Med J 58:112-113
220. Allen CF, Edwards M, Williamson LM et al (2006) Sexually transmitted infection service use and risk factors for HIV infection among female sex workers in Georgetown, Guyana. J Acquir Immune Defic Syndr 43:96-101
221. Palmer CJ, Validum L, Loeffke B et al (2002) HIV prevalence in a gold mining camp in the Amazon region, Guyana. Emerg Infect Dis 8:330-331
222. van Griensven F, de Lindvan Wijngaarden JW, Baral S, Grulich A (2009) The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 4:300-307
223. Padilla M, Castellanos D, Guilamo-Ramos V, Reyes AM, Sanchez Marte LE, Soriano MA (2008) Stigma, social inequality, and HIV risk disclosure among Dominican male sex workers. Soc Sci Med 67:380-388
224. Finlinson HA, Colon HM, Robles RR, Soto M (2006) Sexual identity formation and AIDS prevention: an exploratory study of non-gay-identified Puerto Rican MSM from working class neighborhoods. AIDS Behav 10:531-539
225. Tabet SR, de Moya EA, Holmes KK et al (1996) Sexual behaviors and risk factors for HIV infection among men who have sex with men in the Dominican Republic. AIDS 10:201-206
226. Gelpi-Acosta C, Hagan H, Jenness SM, Wendel T, Neaigus A (2011) Sexual and injectionrelated risks in Puerto Rican-born injection drug users living in New York City: A mixedmethods analysis. Harm Reduct J 8:28
227. Clatts MC, Rodriguez-Diaz CE, Garcia H, Vargas-Molina RL, Jovet-Toledo GG, Goldsamt LA (2011) Preliminary evidence of significant gaps in continuity of HIV care among excarcerated populations in Puerto Rico. J Int Assoc Phys AIDS Care 10:339-341
228. Colon-Lopez V, Rodriguez-Diaz CE, Ortiz AP, Soto-Salgado M, Suarez E, Perez CM (2011) HIV-related risk behaviors among a sample of men who have sex with men in Puerto Rico: an overview of substance use and sexual practices. Puerto Rico Health Sci J 30:65-68
229. Norman LR, Devieux JG, Rosenberg R, Malow RM (2011) HIV-testing practices and a history of substance use among women living in public housing in Puerto Rico. J Int Assoc Phys AIDS Care 10:260-265
230. Rodriguez-Diaz CE, Reece M, Rivera-Alonso B, Laureano-Landron I, Dodge B, Malow RM (2011) Behind the bars of paradise: HIV and substance use among incarcerated populations in Puerto Rico. J Int Assoc Phys AIDS Care 10:266-272
231. Mino M, Deren S, Colon HM (2011) HIV and drug use in Puerto Rico:findings from the ARIBBA study. J Int Assoc Phys AIDS Care 10:248-259
232. Zerden Lde S, Marilis Lopez L, Lundgren LM (2010) Needle sharing among Puerto Rican injection drug users in Puerto Rico and Massachusetts: place of birth and residence matter. Subst Use Misuse 45:1605-1622
233. Perez CM, Marrero E, Melendez M et al (2010) Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico. BMC Infect Dis 10:76
234. Machado LY, Blanco M, Dubed M, Díaz HM, Ruiz NM, Váldes N, Romay D, Lobaina LI. (2011) HIV Type 1 Genetic Diversity in Newly Diagnosed Cuban Patients. AIDS Res Hum Retroviruses. 2011 Dec 19. [Epub ahead of print] PubMed PMID: 22059433
235. Gorry C (2011) Cuba's national HIV/AIDS program. MEDICC Rev 13:5-8
236. Hsieh YH, Wang YS, de Arazoza H, Lounes R (2010) Modeling secondary level of HIV contact tracing: its impact on HIV intervention in Cuba. BMC Infect Dis 10:194
237. Anderson T (2009) HIV/AIDS in Cuba: lessons and challenges. Rev Panam Salud Publica = Pan Am J Public Health 26:78-86
238. Gorry C (2008) Cuba's HIV/AIDS program: controversy, care and cultural shift. MEDICC Rev 10:10-14
239. Rojas P, Malow R, Ruffin B, Rothe EM, Rosenberg R (2011) The HIV/AIDS epidemic in the Dominican Republic: Key contributing factors. J Int Assoc Phys AIDS Care 10:306-315
240. Halperin DT, de Moya EA, Perez-Then E, Pappas G, Garcia Calleja JM (2009) Understanding the HIV epidemic in the Dominican Republic: a prevention success story in the Caribbean? J Acquir Immune Defic Syndr 51(Suppl 1):S52-S59
241. Garris I, Rodriguez EM, De Moya EA et al (1991) AIDS heterosexual predominance in the Dominican Republic. J Acquir Immune Defic Syndr 4:1173-1178
242. Andrews BE (2011) Prevalence and correlates of HIV testing among Caribbean youth. Int J STD AIDS 22:722-726
243. O'Toole BJ, McConkey R, Casson K, Goetz-Goldberg D, Yazdani A (2007) Knowledge and attitudes of young people in Guyana to HIV/AIDS. Int J STD AIDS 18:193-197
244. Mao L, Kippax SC, Holt M, Prestage GP, Zablotska IB, de Wit JB (2011) Rates of condom and non-condom-based anal intercourse practices among homosexually active men in Australia: deliberate HIV risk reduction? Sex Transm Infect 87:489-493
245. Kang M, Skinner R, Usherwood T (2010) Interventions for young people in Australia to reduce HIV and sexually transmissible infections: a systematic review. Sex Health 7:107-128
246. Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA (2010) Optimal provision of needle and syringe programmes for injecting drug users: A systematic review. Int J Drug Policy 21:335-342
247. Minichiello V, Marino R, Browne J (2001) Knowledge, risk perceptions and condom usage in male sex workers from three Australian cities. AIDS Care 13:387-402
248. Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK (2009) Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. J Infect 58:375-382
249. Falster K, Kaldor JM, Maher L (2009) collaboration of Australian Needle and Syringe Programs. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004. J Urban Health. 2009 Jan;86(1):106-118. PubMed PMID: 18979201; PubMed Central PMCID: PMC2629525
250. Maher L, Li J, Jalaludin B et al (2007) Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia. Drug Acohol Depend 89:244-250
251. Dolan K, Rutter S, Wodak AD (2003) Prison-based syringe exchange programmes: a review of international research and development. Addiction 98:153-158
252. Vallely A, Page A, Dias S et al (2010) The prevalence of sexually transmitted infections in Papua New Guinea: a systematic review and meta-analysis. PLoS One 5:e15586
253. Washington CH, Singer LM, McCaig T et al (2008) The prevalence of HIV infection in women attending antenatal clinics in Fiji. P N G Med J 51:56-59
254. Vanualailai J, Deo A, Sharma B, Chandra S (2003) Nonlinear dynamics of the observed HIVpositive population size in Fiji. Pac Health Dialog 10:45-52
255. Corner H, Rissel C, Smith B et al (2005) Sexual health behaviours among Pacific Island youth in Vanuatu, Tonga and the Federated States of Micronesia. Health Promot J Aus 16:144-150
256. Bushman FD, Nabel GJ, Swanstrom R (2011) HIV: from biology to prevention and treatment, 1st edn. Cold Spring Harbor Laboratory Press, New York
257. Cohen MS, Shaw GM, McMichael AJ, Haynes BF (2011) Acute HIV-1 Infection. N Engl J Med 364:1943-1954
258. Reid SE, Reid CA, Vermund SH (2004) Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. Int J STD AIDS 15:713-716
259. Wilen CB, Tilton JC, Doms RW (2012) HIV: cell binding and entry. In: Bushman FD, Nabel GJ, Swanstrom R (eds) HIV: from biology to prevention and treatment, 1st edn. Cold Spring Harbor Laboratory Press, New York, pp 23-32
260. Robertson DL, Anderson JP, Bradac JA et al (2000) HIV-1 nomenclature proposal. Science 288:55-56
261. Kuiken C, Foley B, Leitner T et al (eds) HIV sequence compendium 2010. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 10-03684, New Mexico
262. Sharp PM, Hahn BH (2010) The evolution of HIV-1 and the origin of AIDS. Biol Sci 365:2487-2494
263. Gao F, Bailes E, Robertson DL et al (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441
264. Kalish ML, Robbins KE, Pieniazek D et al (2004) Recombinant viruses and early global HIV-1 epidemic. Emerg Infect Dis 10:1227-1234
265. Rambaut A, Robertson DL, Pybus OG, Peeters M, Holmes EC (2001) Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature 410:1047-1048
266. Novitsky V, Ndung'u T, Wang R et al (2011) Extended high viremics: a substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection. AIDS 25:1515-1522
267. Novitsky V, Wang R, Lagakos S, Essex M (2010) HIV-1 subtype C phylodynamics in the global epidemic. Viruses 2:33-54
268. Hemelaar J, Gouws E, Ghys PD, Osmanov S (2011) WHO-UNAIDS Network for HIV Isolation and Characterisation. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS. 2011 Mar 13;25(5):679-689. PubMed PMID: 21297424
269. Rambaut A, Posada D, Crandall KA, Holmes EC (2004) The causes and consequences of HIV evolution. Nat Rev Genet 5:52-61
270. Veras NM, Gray RR, Brigido LF, Rodrigues R, Salemi M (2011) High-resolution phylogenetics and phylogeography of human immunodeficiency virus type 1 subtype C epidemic in South America. J Gen Virol 92:1698-1709
271. Lewis F, Hughes GJ, Rambaut A, Pozniak A, Leigh Brown AJ (2008) Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 5:e50
272. Suchard MA, Weiss RE, Sinsheimer JS (2001) Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol 18:1001-1013
273. Korber B, Muldoon M, Theiler J et al (2000) Timing the ancestor of the HIV-1 pandemic strains. Science 288:1789-1796
274. Gifford RJ, de Oliveira T, Rambaut A et al (2007) Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. J Virol 81:13050-13056
275. Takebe Y, Liao H, Hase S et al (2010) Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: the relevance of genetic diversity and phylodynamics for vaccine strategies. Vaccine 28(Suppl 2):B39-B44
276. Hughes GJ, Fearnhill E, Dunn D et al (2009) Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog 5:e1000590
277. Deng X, Liu H, Shao Y, Rayner S, Yang R (2008) The epidemic origin and molecular properties of B ¢: a founder strain of the HIV-1 transmission in Asia. AIDS 22:1851-1858
278. Shafer RW, Rhee SY, Bennett DE (2008) Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. Antivir Ther 13(Suppl 2):59-68
279. Mitsuya H, Broder S (1987) Strategies for antiviral therapy in AIDS. Nature 325:773-778
280. Broder S (2010) Twenty-five years of translational medicine in antiretroviral therapy: promises to keep. Sci Transl Med 2:39ps3
281. Broder S (2010) The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res 85:1-18
282. Mitsuya H, Yarchoan R, Kageyama S, Broder S (1991) Targeted therapy of human immunodeficiency virus-related disease. FASEB J 5:2369-2381
283. Maeda K, Mitsuya H (2007) Development of therapeutics for AIDS: structure-based molecular targeting. Tuberculosis 87(Suppl 1):S31-S34
284. Volberding PA, Lagakos SW, Koch MA et al (1990) Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med 322:941-949
285. Fischl MA, Richman DD, Hansen N et al (1990) The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med 112:727-737
286. Graham NM, Zeger SL, Park LP et al (1992) The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 326:1037-1042
287. Graham NM, Zeger SL, Park LP et al (1991) Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet 338:265-269
288. Concorde Coordinating Committee (1994) Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343:871-881
289. Volberding PA, Lagakos SW, Grimes JM et al (1994) The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA 272:437-442
290. Vella S, Giuliano M, Dally LG et al (1994) Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group. J Acquir Immune Defic Syndr 7:31-38
291. Gardner LI, Harrison SH, Hendrix CW et al (1998) Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research. J Acquir Immune Defic Syndr 17:345-353
292. Simberkoff MS, Hartigan PM, Hamilton JD et al (1996) Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment. J Acquir Immune Defic Syndr 11:142-150
293. Ioannidis JP, Cappelleri JC, Lau J et al (1995) Early or deferred zidovudine therapy in HIVinfected patients without an AIDS-defining illness. Ann Intern Med 122:856-866
294. Volberding PA, Lagakos SW, Grimes JM et al (1995) A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med 333:401-407
295. Cooper DA, Gatell JM, Kroon S et al (1993) Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. N Engl J Med 329:297-303
296. Thompson MA, Aberg JA, Cahn P et al (2010) Antiretroviral treatment of adult HIV infection:2010 recommendations of the International AIDS Society-USA panel. JAMA 304:321-333
297. Dionisio D, Gass R, McDermott P et al (2007) What strategies to boost production of affordablefixed-dose anti-retroviral drug combinations for children in the developing world? Curr HIV Res 5:155-187
298. Holmes CB, Coggin W, Jamieson D et al (2010) Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs. JAMA 304:313-320
299. Marques UR, Guimaraes VS, Sternberg C (2005) Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing. Food Drug Law J 60:471-477
300. Waning B, Kyle M, Diedrichsen E et al (2010) Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Global Health 6:9
301. Parra J, Portilla J, Pulido F et al (2011) Clinical utility of maraviroc. Clin Drug Invest 31:527-542
302. Nel A, Kagee A (2011) Common mental health problems and antiretroviral therapy adherence. AIDS Care 23:1360-1365
303. Gonzalez A, Barinas J, O'Cleirigh C (2011) Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep 8:223-234
304. Blashill AJ, Perry N, Safren SA (2011) Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Curr HIV/AIDS Rep 8:215-222
305. Meyer JP, Springer SA, Altice FL (2011) Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Women's Health 20:991-1006
306. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH (2010) Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 376:367-387
307. Bravo P, Edwards A, Rollnick S, Elwyn G (2010) Tough decisions faced by people living with HIV: a literature review of psychosocial problems. AIDS Rev 12:76-88
308. Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J (2010) Causal considerations on alcohol and HIV/AIDS-a systematic review. Alcohol Alcohol 45:159-166
309. Kresina TF, Bruce RD, McCance-Katz EF (2009) Medication assisted treatment in the treatment of drug abuse and dependence in HIV/AIDS infected drug users. Curr HIV Res 7:354-364
310. Fuller BE, Loftis JM, Rodriguez VL, McQuesten MJ, Hauser P (2009) Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfection. Curr Opin Psychiatry 22:401-408
311. Pence BW (2009) The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother 63:636-640
312. Stirratt MJ, Gordon CM (2008) Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research. Curr HIV/AIDS Rep 5:186-192
313. Whetten K, Reif S, Whetten R, Murphy-McMillan LK (2008) Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med 70:531-538
314. Hartzell JD, Janke IE, Weintrob AC (2008) Impact of depression on HIV outcomes in the HAART era. J Antimicrob Chemother 62:246-255
315. Ingersoll KS, Cohen J (2008) The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 31:213-224
316. Remien RH, Mellins CA (2007) Long-term psychosocial challenges for people living with HIV: let's not forget the individual in our global response to the pandemic. AIDS 21 (Suppl 5):S55-S63
317. Patel V, Araya R, Chatterjee S et al (2007) Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 370:991-1005
318. Conway B (2007) The role of adherence to antiretroviral therapy in the management of HIV infection. J Acquir Immune Defic Syndr 45(Suppl 1):S14-S18
319. Olatunji BO, Mimiaga MJ, O'Cleirigh C, Safren SA (2006) Review of treatment studies of depression in HIV. Top HIV Med 14:112-124
320. Springer SA, Altice FL (2005) Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep 2:165-170
321. Chander G, Himelhoch S, Moore RD (2006) Substance abuse and psychiatric disorders in HIVpositive patients: epidemiology and impact on antiretroviral therapy. Drugs 66:769-789
322. Lauby JL, Marks G, Bingham T et al (2012) Having supportive social relationships is associated with reduced risk of unrecognized HIV infection among black and Latino men who have sex with men. AIDS Behav 16:508-515
323. Millett GA, Ding H, Marks G et al (2011) Mistaken assumptions and missed opportunities: correlates of undiagnosed HIV infection among black and Latino men who have sex with men. J Acquir Immune Defic Syndr 58:64-71
324. Reisner SL, Mimiaga MJ, Bland S et al (2010) Problematic alcohol use and HIV risk among Black men who have sex with men in Massachusetts. AIDS Care 22:577-587
325. Mimiaga MJ, Reisner SL, Fontaine YM et al (2010) Walking the line: stimulant use during sex and HIV risk behavior among Black urban MSM. Drug Alcohol Depend 110:30-37
326. Mimiaga MJ, Reisner SL, Bland S et al (2009) Health system and personal barriers resulting in decreased utilization of HIV and STD testing services among at-risk black men who have sex with men in Massachusetts. AIDS Patient Care STDS 23:825-835
327. Reisner SL, Mimiaga MJ, Skeer M et al (2009) Clinically significant depressive symptoms as a risk factor for HIV infection among black MSM in Massachusetts. AIDS Behav 13:798-810
328. Bond L, Wheeler DP, Millett GA, LaPollo AB, Carson LF, Liau A (2009) Black men who have sex with men and the association of down-low identity with HIV risk behavior. Am J Public Health 99(Suppl 1):S92-S95
329. Lauby JL, Millett GA, LaPollo AB, Bond L, Murrill CS, Marks G (2008) Sexual risk behaviors of HIV-positive, HIV-negative, and serostatus-unknown Black men who have sex with men and women. Arch Sex Behav 37:708-719
330. DeLaMora P, Aledort N, Stavola J (2006) Caring for adolescents with HIV. Curr HIV/AIDS Rep 3:74-78
331. Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA (2009) A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med 17:14-25
332. Dowshen N, D'Angelo L (2011) Health care transition for youth living with HIV/AIDS. Pediatrics 128:762-771
333. Koenig LJ, Nesheim S, Abramowitz S (2011) Adolescents with perinatally acquired HIV: emerging behavioral and health needs for long-term survivors. Curr Opin Obstet Gynecol 23:321-327
334. Murphy DA, Moscicki AB, Vermund SH, Muenz LR (2000) Psychological distress among HIV(+) adolescents in the REACH study: effects of life stress, social support, and coping. The Adolescent Medicine HIV/AIDS Research Network. J Adolesc Health 27:391-398
335. Murphy DA, Durako SJ, Moscicki AB et al (2001) No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health 29:57-63
336. Vermund SH, Wilson CM, Rogers AS, Partlow C, Moscicki AB (2001) Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health 29:49-56
337. Murphy DA, Mitchell R, Vermund SH, Futterman D, Adolescent Medicine HIVARN (2002) Factors associated with HIV testing among HIV-positive and HIV-negative high-risk adolescents: the REACH Study. Reaching for Excellence in Adolescent Care and Health. Pediatrics 110:e36
338. Yanagisawa S, Poudel KC, Jimba M (2010) Sibling caregiving among children orphaned by AIDS: synthesis of recent studies for policy implications. Health Policy 98:121-130
339. Zhao G, Li X, Fang X, Zhao J, Yang H, Stanton B (2007) Care arrangements, grief and psychological problems among children orphaned by AIDS in China. AIDS Care 19:1075-1082
340. Bhargava A, Bigombe B (2003) Public policies and the orphans of AIDS in Africa. BMJ 326:1387-1389
341. Vaz LM, Maman S, Eng E, Barbarin OA, Tshikandu T, Behets F (2011) Patterns of Disclosure of HIV Status to Infected Children in a Sub-Saharan African Setting. J Dev Behav Pediatr. 2011 Feb 11. [Epub ahead of print] PubMed PMID: 21317803; PubMed Central PMCID: PMC3128187
342. Vaz LM, Eng E, Maman S, Tshikandu T, Behets F (2010) Telling children they have HIV: lessons learned fromfindings of a qualitative study in sub-Saharan Africa. AIDS Patient Care STDS 24:247-256
343. Corneli A, Vaz L, Dulyx J, Omba S, Rennie S, Behets F (2009) The role of disclosure in relation to assent to participate in HIV-related research among HIV-infected youth: a formative study. J Int AIDS Soc 12:17
344. Vaz L, Corneli A, Dulyx J et al (2008) The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. AIDS Care 20:842-852
345. Walensky RP, Paltiel AD, Losina E et al (2006) The survival benefits of AIDS treatment in the United States. J Infect Dis 194:11-19
346. Vermund SH (2006) Millions of life-years saved with potent antiretroviral drugs in the United States: a celebration, with challenges. J Infect Dis 194:1-5
347. Lundgren JD, Mocroft A (2006) The impact of antiretroviral therapy on AIDS and survival. J HIV Ther 11:36-38
348. McCoy D, Chopra M, Loewenson R et al (2005) Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities. Am J Public Health 95:18-22
349. Schwartlander B, Grubb I, Perriens J (2006) The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world. Lancet 368:541-546
350. Ojikutu B (2007) Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation. J Infect Dis 196(Suppl 3): S445-S448
351. Rosen S, Sanne I, Collier A, Simon JL (2005) Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences. PLoS Med 2:e303
352. Lamptey P, Wilson D (2005) Scaling up AIDS treatment: what is the potential impact and what are the risks? PLoS Med 2:e39
353. Vermund SH, Sidat M, Weil LF et al (2012) Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS 26(10):1303-1310
354. Moon TD, Burlison JR, Sidat M et al (2010) Lessons Learned while Implementing an HIV/AIDs care and treatment program in rural Mozambique. Retrovir Res Treat 3:1-14
355. Menzies NA, Berruti AA, Berzon R et al (2011) The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. AIDS 25:1753-1760
356. Filler SJ, Berruti AA, Menzies N et al (2011) Characteristics of HIV care and treatment in PEPFAR-supported sites. J Acquir Immune Defic Syndr 57:e1-e6
357. Stringer JS, Zulu I, Levy J et al (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296:782-793
358. Banda Y, Chapman V, Goldenberg RL et al (2007) Use of traditional medicine among pregnant women in Lusaka, Zambia. J Altern Complement Med 13:123-127
359. Klausner JD, Serenata C, O'Bra H et al (2011) Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009. J Acquir Immune Defic Syndr 56:292-295
360. Biesma RG, Brugha R, Harmer A, Walsh A, Spicer N, Walt G (2009) The effects of global health initiatives on country health systems: a review of the evidence from HIV/AIDS control. Health Policy Plan 24:239-252
361. Abimiku AG, Institute of Human Virology UoMSoMPP (2009) Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience. Am J Clin Pathol 131:875-886
362. Yiannoutsos CT, An MW, Frangakis CE et al (2008) Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One 3:e3843
363. Schoni-Affolter F, Keiser O, Mwango A et al (2011) Estimating loss to follow-up in HIVinfected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Swaziland. PLoS One 6:e27919
364. Moon TD, Burlison JR, Blevins M et al (2011) Enrolment and programmatic trends and predictors of antiretroviral therapy initiation from president's emergency plan for AIDS Relief (PEPFAR)-supported public HIV care and treatment sites in rural Mozambique. Int J STD AIDS 22:621-627
365. Groh K, Audet CM, Baptista A et al (2011) Barriers to antiretroviral therapy adherence in rural Mozambique. BMC Public Health 11:650
366. Cook RE, Ciampa PJ, Sidat M et al (2011) Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique. J Acquir Immune Defic Syndr 56:e104-e109
367. Koethe JR, Limbada MI, Giganti MJ et al (2010) Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia. AIDS 24:2117-2121
368. Giganti MJ, Levy JW, Banda Y et al (2010) Methods and baseline results of a repeated crosssectional survey to assess the public health impact of antiretroviral therapy in Lusaka, Zambia. Am J Trop Med Hyg 82:971-977
369. Chi BH, Cantrell RA, Mwango A et al (2010) An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol 171:924-931
370. Morris MB, Chapula BT, Chi BH et al (2009) Use of task-shifting to rapidly scale-up HIV treatment services: experiences from Lusaka, Zambia. BMC Health Serv Res 9:5
371. Krebs DW, Chi BH, Mulenga Y et al (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20:311-317
372. Mahajan AP, Sayles JN, Patel VA et al (2008) Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward. AIDS 22(Suppl 2):S67-S79
373. Whitmore SK, Zhang X, Taylor AW, Blair JM (2011) Estimated number of infants born to HIV-infected women in the United States andfive dependent areas, 2006. J Acquir Immune Defic Syndr 57(3):218-222
374. Whitmore SK, Patel-Larson A, Espinoza L, Ruffo NM, Rao S (2010) Missed opportunities to prevent perinatal human immunodeficiency virus transmission in 15 jurisdictions in the United States during 2005-2008. Women Health 50:414-425
375. Birkhead GS, Pulver WP, Warren BL, Hackel S, Rodriguez D, Smith L (2010) Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006. Obstet Gynecol 115:1247-1255
376. Centers for Disease Control and Prevention (CDC) (2010) Racial/ethnic disparities among children with diagnoses of perinatal HIV infection - 34 states, 2004-2007. MMWR Morb Mortal Wkly Rep 59:97-101. Erratum in: MMWR Morb Mortal Wkly Rep. 2010 Feb 12;59(5):136. PubMed PMID: 20134398
377. Dwyre DM, Fernando LP, Holland PV (2011) Hepatitis B, hepatitis C and HIV transfusiontransmitted infections in the 21st century. Vox Sang 100:92-98
378. Barth RE, Huijgen Q, Taljaard J, Hoepelman AI (2010) Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis 14:e1024-e1031
379. Mahy M, Warner-Smith M, Stanecki KA, Ghys PD (2009) Measuring the impact of the global response to the AIDS epidemic: challenges and future directions. J Acquir Immune Defic Syndr 52(Suppl 2):S152-S159
380. Xvi PB, Seewald P (2010) Light of the world: the Pope, the Church, and the Signs of the Times, 1st edn. Ignatius Press, San Francisco
381. Koblin BA, Chesney MA, Husnik MJ et al (2003) High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. Am J Public Health 93:926-932
382. Chesney MA, Koblin BA, Barresi PJ et al (2003) An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study. Am J Public Health 93:933-938
383. Koblin B, Chesney M, Coates T (2004) Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet 364:41-50
384. Colfax G, Vittinghoff E, Husnik MJ et al (2004) Substance use and sexual risk: a participantand episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol 159:1002-1012
385. Colfax G, Coates TJ, Husnik MJ et al (2005) Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health 82:i62-i70
386. Salomon EA, Mimiaga MJ, Husnik MJ et al (2009) Depressive symptoms, utilization of mental health care, substance use and sexual risk among young men who have sex with men in EXPLORE: implications for age-specific interventions. AIDS Behav 13:811-821
387. El-Bassel N, Gilbert L, Witte S, Wu E, Hunt T, Remien RH (2010) Couple-based HIV prevention in the United States: advantages, gaps, and future directions. J Acquir Immune Defic Syndr 55(Suppl 2):S98-S101
388. Crawford ND, Vlahov D (2010) Progress in HIV reduction and prevention among injection and noninjection drug users. J Acquir Immune Defic Syndr 55(Suppl 2):S84-S87
389. Read JS (2010) Prevention of mother-to-child transmission of HIV: antiretroviral strategies. Clin Perinatol 37:765-776
390. Cohen MS, Gay CL, Busch MP, Hecht FM (2010) The detection of acute HIV infection. J Infect Dis 202(Suppl 2):S270-S277
391. Reynolds SJ, Quinn TC (2010) Setting the stage: current state of affairs and major challenges. Clin Infect Dis 50(Suppl 3):S71-S76
392. DeGruttola V, Smith DM, Little SJ, Miller V (2010) Developing and evaluating comprehensive HIV infection control strategies: issues and challenges. Clin Infect Dis 50(Suppl 3):S102-S107
393. Buchbinder S (2009) The epidemiology of new HIV infections and interventions to limit HIV transmission. Top HIV Med 17:37-43
394. Rotheram-Borus MJ, Swendeman D, Chovnick G (2009) The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol 5:143-167
395. Barrow RY, Berkel C, Brooks LC, Groseclose SL, Johnson DB, Valentine JA (2008) Traditional sexually transmitted disease prevention and control strategies: tailoring for African American communities. Sex Transm Dis 35:S30-S39
396. Margaret Dolcini M, Gandelman AA, Vogan SA et al (2010) Translating HIV interventions into practice: community-based organizations' experiences with the diffusion of effective behavioral interventions (DEBIs). Soc Sci Med 71:1839-1846
397. Harshbarger C, Simmons G, Coelho H, Sloop K, Collins C (2006) An empirical assessment of implementation, adaptation, and tailoring: the evaluation of CDC's national diffusion of VOICES/VOCES. AIDS Educ Prev 18:184-197
398. Wingood GM, DiClemente RJ (2006) Enhancing adoption of evidence-based HIV interventions: promotion of a suite of HIV prevention interventions for African American women. AIDS Educ Prev 18:161-170
399. Collins C, Harshbarger C, Sawyer R, Hamdallah M (2006) The diffusion of effective behavioral interventions project: development, implementation, and lessons learned. AIDS Educ Prev 18:5-20
400. Lyles CM, Crepaz N, Herbst JH, Kay LS (2006) Evidence-based HIV behavioral prevention from the perspective of the CDC's HIV/AIDS Prevention Research Synthesis Team. AIDS Educ Prev 18:21-31
401. Ott MA, Santelli JS (2007) Abstinence and abstinence-only education. Curr Opin Obstet Gynecol 19:446-452
402. Kohler PK, Manhart LE, Lafferty WE (2008) Abstinence-only and comprehensive sex education and the initiation of sexual activity and teen pregnancy. J Adolesc Health 42:344-351
403. Trenholm C, Devaney B, Fortson K, Clark M, Bridgespan LQ, Wheeler J (2008) Impacts of abstinence education on teen sexual activity, risk of pregnancy, and risk of sexually transmitted diseases. J Policy Anal Manage 27:255-276
404. Dworkin SL, Ehrhardt AA (2007) Going beyond "ABC" to include "GEM": critical re flections on progress in the HIV/AIDS epidemic. Am J Public Health 97:13-18
405. Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN (2011) Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep 8:62-72
406. Glasgow RE, Vogt TM, Boles SM (1999) Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health 89:1322-1327
407. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2:e298
408. Bailey RC, Moses S, Parker CB et al (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369:643-656
409. Gray RH, Kigozi G, Serwadda D et al (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369:657-666
410. Connor EM, Sperling RS, Gelber R et al (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173-1180
411. Fideli US, Allen SA, Musonda R et al (2001) Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 17:901-910
412. Quinn TC, Wawer MJ, Sewankambo N et al (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1 Rakai Project Study Group. N Engl J Med 342:921-929
413. Korenromp EL, White RG, Orroth KK et al (2005) Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 191(Suppl 1):S168-S178
414. Abdool Karim Q, Abdool Karim SS, Frohlich JA et al (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168-1174
415. Grant RM, Lama JR, Anderson PL et al (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363:2587-2599
416. Celum C, Baeten JM (2012) Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis 25:51-57
417. Krakower D, Mayer KH (2011) Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications. Curr HIV/AIDS Rep 8:241-248
418. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S et al (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209-2220
419. Johnston MI, Fauci AS (2011) HIV vaccine development-improving on natural immunity. N Engl J Med 365:873-875
420. Denison JA, O'Reilly KR, Schmid GP, Kennedy CE, Sweat MD (2008) HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990-2005. AIDS Behav 12:363-373
421. Allen S, Tice J, Van de Perre P et al (1992) Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ 304:1605-1609
422. Wilson D, Halperin DT (2008) "Know your epidemic, know your response": a useful approach, if we get it right. Lancet 372:423-426
423. Khumalo-Sakutukwa G, Morin SF, Fritz K et al (2008) Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr 49:422-431
424. Sweat M, Morin S, Celentano D et al (2011) Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 11:525-532
425. Stoneburner RL, Low-Beer D (2004) Sexual partner reductions explain human immunodeficiency virus declines in Uganda: comparative analyses of HIV and behavioural data in Uganda, Kenya, Malawi, and Zambia. Int J Epidemiol 33:624
426. Bunnell R, Cherutich P (2008) Universal HIV testing and counselling in Africa. Lancet 371:2148-2150
427. Renaud-Thery FDC, Ken S, Thierry S, Perriens J (2010) Adult antiretroviral therapy in resource limited settings: a systematic review offirst-line treatment failure and attrition rates. In: 17th conference on retroviruses and opportunistic Infections, San Francisco, CA
428. Bunnell R, Ekwaru JP, Solberg P et al (2006) Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 20:85-92
429. Vandenbruaene M (2007) Interview: King Kennard Holmes-chair of the Department of Global Health of the University of Washington. Lancet Infect Dis 7:516-520
430. Wagner B, Blower S (2010) Costs of eliminating HIV in South Africa have been underestimated. Lancet 376:953-954
431. Wilson DP, Blower SM (2005) Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med 2:e50
432. Wagner BG, Kahn JS, Blower S (2010) Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? AIDS 24:775-776